Prime Medicine (PRME) Non Operating Income (2021 - 2026)

Prime Medicine has reported Non Operating Income for 6 years, with the latest figure at $1.5 million in Q1 2026.

• For the quarter ending Q1 2026, Non Operating Income rose 205.18% year-over-year to $1.5 million; the trailing twelve-month figure through Mar 2026 stood at $8.2 million (up 242.68% YoY), and the FY2025 full-year result was $7.2 million, up 9.46% from the prior year.
• Non Operating Income for Q1 2026 stood at $1.5 million, down from $2.5 million in the prior quarter.
• The five-year high for Non Operating Income was $3.4 million in Q3 2025, with the low at -$7.2 million in Q4 2022.
• Historically, Non Operating Income has averaged $435588.2 across 5 years, with a median of $643000.0 in 2023.
• Annual changes were most pronounced in 2022 — Non Operating Income soared 72900.0% — and 2024, when it slumped 112.91%.
• Prime Medicine's Non Operating Income stood at -$7.2 million in 2022, then soared by 48.54% to -$3.7 million in 2023, then surged by 152.51% to $1.9 million in 2024, then climbed by 29.96% to $2.5 million in 2025, then plunged by 39.42% to $1.5 million in 2026.
• The last three Non Operating Income figures came in at $1.5 million (Q1 2026), $2.5 million (Q4 2025), and $3.4 million (Q3 2025), per Business Quant data.